Skip to main content
Top
Published in: European Journal of Medical Research 1/2014

Open Access 01-12-2014 | Research

Left ventricular remodeling with preserved function after coronary microembolization: the effect of methylprednisolone

Authors: Jianying Ma, Juying Qian, Shufu Chang, Zhangwei Chen, Hang Jin, Mengsu Zeng, Yunzeng Zou, Junbo Ge

Published in: European Journal of Medical Research | Issue 1/2014

Login to get access

Abstract

Background

The objective of this study was to evaluate changes in left ventricular ejection fraction (LVEF) and left ventricular remodeling after coronary microembolization (CME) and to investigate the protective effects of methylprednisolone (MTP).

Methods

CME was induced by injection of microspheres (42 μm Dynospheres) into left anterior descending artery of mini swine. The animals were divided into two groups. Group 1 (n = 9) received 120,000 microspheres and Group 2 (n = 7) received 120,000 microspheres following intravenous administration of 30 mg/kg MTP. Contrast-enhanced magnetic resonance imaging (CeMRI) was performed at baseline, 6 h after intervention, and 1 week later.

Results

In Group 1, LVEF was significantly decreased at 6 h but recovered 1 week. This was accompanied by continuing left ventricular remodeling. In Group 2, LVEF remained unchanged at all assessment times. LVEF measured at 6 h and 1 week after CME in Group 1 and Group 2 was 0.39 ± 0.06 and 0.44 ± 0.04, and 0.44 ± 0.04 and 0.48 ± 0.03, respectively (Both P >0.05). Hyperenchancement at the anterior wall of the left ventricle was shown by MRI at 6 h in Group 1 but not in Group 2. The hyperenhanced area in Group 1 was 7.77 ± 1.49% of left ventricular mass.

Conclusions

The consequence of CME is left ventricular dilation with preserved LVEF. Pretreatment with MTP appears to have a cardioprotective effect on left ventricular remodeling.
Appendix
Available only for authorised users
Literature
1.
go back to reference Heusch G, Kleinbongard P, Böse D, Levkau B, Haude M, Schulz R, Erbel R: Coronary microembolization: from bedside to bench and back to bedside. Circulation 2009, 120: 1822–1836. 10.1161/CIRCULATIONAHA.109.888784PubMedCrossRef Heusch G, Kleinbongard P, Böse D, Levkau B, Haude M, Schulz R, Erbel R: Coronary microembolization: from bedside to bench and back to bedside. Circulation 2009, 120: 1822–1836. 10.1161/CIRCULATIONAHA.109.888784PubMedCrossRef
2.
go back to reference Dörge H, Neumann T, Behrends M, Skyschally A, Schulz R, Kasper C, Erbel R, Heusch G: Perfusion-contraction mismatch with coronary microvascular obstruction: role of inflammation. Am J Physiol Heart Circ Physiol 2000, 279: H2587-H2592.PubMed Dörge H, Neumann T, Behrends M, Skyschally A, Schulz R, Kasper C, Erbel R, Heusch G: Perfusion-contraction mismatch with coronary microvascular obstruction: role of inflammation. Am J Physiol Heart Circ Physiol 2000, 279: H2587-H2592.PubMed
3.
go back to reference Thielmann M, Dörge H, Martin C, Belosjorow S, Schwanke U, van de Sand A, Konietzka I, Büchert A, Krüger A, Schulz R, Heusch G: Myocardial dysfunction with coronary microembolization: signal transduction through a sequence of nitric oxide, tumor necrosis factor-α and sphingosine. Circ Res 2002, 90: 807–813. 10.1161/01.RES.0000014451.75415.36PubMedCrossRef Thielmann M, Dörge H, Martin C, Belosjorow S, Schwanke U, van de Sand A, Konietzka I, Büchert A, Krüger A, Schulz R, Heusch G: Myocardial dysfunction with coronary microembolization: signal transduction through a sequence of nitric oxide, tumor necrosis factor-α and sphingosine. Circ Res 2002, 90: 807–813. 10.1161/01.RES.0000014451.75415.36PubMedCrossRef
4.
go back to reference Skyschally A, Haude M, Dörge H, Thielmann M, Duschin A, van de Sand A, Konietzka I, Büchert A, Aker S, Massoudy P, Schulz R, Erbel R, Heusch G: Glucocorticoid treatment prevents progressive myocardial dysfunction resulting from experimental coronary microembolization. Circulation 2004, 109: 2337–2342. 10.1161/01.CIR.0000127961.66744.F4PubMedCrossRef Skyschally A, Haude M, Dörge H, Thielmann M, Duschin A, van de Sand A, Konietzka I, Büchert A, Aker S, Massoudy P, Schulz R, Erbel R, Heusch G: Glucocorticoid treatment prevents progressive myocardial dysfunction resulting from experimental coronary microembolization. Circulation 2004, 109: 2337–2342. 10.1161/01.CIR.0000127961.66744.F4PubMedCrossRef
5.
go back to reference Dörge H, Schulz R, Belosjorow S, Post H, van de Sand A, Konietzka I, Frede S, Hartung T, Vinten-Johansen J, Youker KA, Entman ML, Erbel R, Heusch G: Coronary microembolization: the role of TNF-alpha in contractile dysfunction. J Mol Cell Cardiol 2002, 34: 51–62. 10.1006/jmcc.2001.1489PubMedCrossRef Dörge H, Schulz R, Belosjorow S, Post H, van de Sand A, Konietzka I, Frede S, Hartung T, Vinten-Johansen J, Youker KA, Entman ML, Erbel R, Heusch G: Coronary microembolization: the role of TNF-alpha in contractile dysfunction. J Mol Cell Cardiol 2002, 34: 51–62. 10.1006/jmcc.2001.1489PubMedCrossRef
6.
go back to reference Heusch P, Skyschally A, Leineweber K, Haude M, Erbel R, Heusch G: The interaction of coronary microembolization and ischemic preconditioning: a third window of cardioprotection through TNF-alpha. Arch Med Sci 2007, 3: 83–92. Heusch P, Skyschally A, Leineweber K, Haude M, Erbel R, Heusch G: The interaction of coronary microembolization and ischemic preconditioning: a third window of cardioprotection through TNF-alpha. Arch Med Sci 2007, 3: 83–92.
7.
go back to reference Li S, Zhong S, Zeng K, Luo Y, Zhang F, Sun X, Chen L: Blockade of NF-κB by pyrrolidine dithiocarbamate attenuates myocardial inflammatory response and ventricular dysfunction following coronary microembolization induced by homologous microthrombi in rats. Basic Res Cardiol 2010, 105: 139–150. 10.1007/s00395-009-0067-6PubMedCrossRef Li S, Zhong S, Zeng K, Luo Y, Zhang F, Sun X, Chen L: Blockade of NF-κB by pyrrolidine dithiocarbamate attenuates myocardial inflammatory response and ventricular dysfunction following coronary microembolization induced by homologous microthrombi in rats. Basic Res Cardiol 2010, 105: 139–150. 10.1007/s00395-009-0067-6PubMedCrossRef
8.
go back to reference Ma J, Qian J, Jin H, Chen Z, Chang S, Yang S, Sun AJ, Zeng MS, Zou YZ, Ge JB: Acute hyperenhancement on delayed contrast-enhanced magnetic resonance imaging is the characteristic sign after coronary microembolization. Chin Med J 2009, 122: 687–691.PubMed Ma J, Qian J, Jin H, Chen Z, Chang S, Yang S, Sun AJ, Zeng MS, Zou YZ, Ge JB: Acute hyperenhancement on delayed contrast-enhanced magnetic resonance imaging is the characteristic sign after coronary microembolization. Chin Med J 2009, 122: 687–691.PubMed
9.
go back to reference Ma J, Qian J, Ge J, Zeng X, Sun A, Chang S, Chen Z, Zou Y: Changes in left ventricular ejection fraction and coronary flow reserve after coronary microembolization. Arch Med Sci 2012, 8: 63–69.PubMedPubMedCentralCrossRef Ma J, Qian J, Ge J, Zeng X, Sun A, Chang S, Chen Z, Zou Y: Changes in left ventricular ejection fraction and coronary flow reserve after coronary microembolization. Arch Med Sci 2012, 8: 63–69.PubMedPubMedCentralCrossRef
10.
go back to reference Breuckmann F, Nassenstein K, Bucher C, Konietzka I, Kaiser G, Konorza T, Naber C, Skyschally A, Gres P, Heusch G, Erbel R, Barkhausen J: Systematic analysis of functional and structural changes after coronary microembolization: a cardiac magnetic resonance imaging study. J Am Coll Cardiol Img 2009, 2: 121–130. 10.1016/j.jcmg.2008.10.011CrossRef Breuckmann F, Nassenstein K, Bucher C, Konietzka I, Kaiser G, Konorza T, Naber C, Skyschally A, Gres P, Heusch G, Erbel R, Barkhausen J: Systematic analysis of functional and structural changes after coronary microembolization: a cardiac magnetic resonance imaging study. J Am Coll Cardiol Img 2009, 2: 121–130. 10.1016/j.jcmg.2008.10.011CrossRef
11.
go back to reference Carlsson M, Wilson M, Martin AJ, Saeed M: Myocardial microinfarction after coronary microembolization in swine: MR imaging characterization. Radiology 2009, 250: 703–713. 10.1148/radiol.2503081000PubMedPubMedCentralCrossRef Carlsson M, Wilson M, Martin AJ, Saeed M: Myocardial microinfarction after coronary microembolization in swine: MR imaging characterization. Radiology 2009, 250: 703–713. 10.1148/radiol.2503081000PubMedPubMedCentralCrossRef
12.
go back to reference Cranney GB, Lotan CS, Dean L, Baxley W, Bouchard A, Pohost GM: Left ventricular volume measurement using cardiac axis nuclear magnetic resonance imaging. Validation by calibrated ventricular angiography. Circulation 1990, 82: 154–163. 10.1161/01.CIR.82.1.154PubMedCrossRef Cranney GB, Lotan CS, Dean L, Baxley W, Bouchard A, Pohost GM: Left ventricular volume measurement using cardiac axis nuclear magnetic resonance imaging. Validation by calibrated ventricular angiography. Circulation 1990, 82: 154–163. 10.1161/01.CIR.82.1.154PubMedCrossRef
13.
go back to reference Herrogods M, De Paep G, Bijnens B, Bogaert JG, Rademakers FE, Bosmans HT, Bellon EP, Marchal GJ, Baert AL, Van de Werf F, De Geest H: Determination of left ventricular volume by two-dimensional echocardiography: comparison with magnetic resonance imaging. Eur Heart J 1994, 15: 1070–1073. Herrogods M, De Paep G, Bijnens B, Bogaert JG, Rademakers FE, Bosmans HT, Bellon EP, Marchal GJ, Baert AL, Van de Werf F, De Geest H: Determination of left ventricular volume by two-dimensional echocardiography: comparison with magnetic resonance imaging. Eur Heart J 1994, 15: 1070–1073.
14.
go back to reference Falkenstein E, Tillmann H-C, Christ M, Feuring M, Wehling M: Multiple actions of steroid hormones: a focus on rapid, nongenomic effects. Pharmacol Rev 2000, 52: 513–555.PubMed Falkenstein E, Tillmann H-C, Christ M, Feuring M, Wehling M: Multiple actions of steroid hormones: a focus on rapid, nongenomic effects. Pharmacol Rev 2000, 52: 513–555.PubMed
15.
go back to reference Giugliano GR, Giugliano RP, Gibson CM, Kuntz RE: Meta-analysis of corticosteroid treatment in acute myocardial infarction. Am J Cardiol 2003, 91: 1055–1059. 10.1016/S0002-9149(03)00148-6PubMedCrossRef Giugliano GR, Giugliano RP, Gibson CM, Kuntz RE: Meta-analysis of corticosteroid treatment in acute myocardial infarction. Am J Cardiol 2003, 91: 1055–1059. 10.1016/S0002-9149(03)00148-6PubMedCrossRef
16.
go back to reference Otto S, Seeber M, Fujita B, Kretzschmar D, Ferrari M, Goebel B, Figulla HR, Poerner TC: Microembolization and myonecrosis during elective percutaneous coronary interventions in diabetic patients: an intracoronary Doppler ultrasound study with 2-year clinical follow-up. Basic Res Cardiol 2012, 107: 289.PubMedCrossRef Otto S, Seeber M, Fujita B, Kretzschmar D, Ferrari M, Goebel B, Figulla HR, Poerner TC: Microembolization and myonecrosis during elective percutaneous coronary interventions in diabetic patients: an intracoronary Doppler ultrasound study with 2-year clinical follow-up. Basic Res Cardiol 2012, 107: 289.PubMedCrossRef
17.
go back to reference Falk E: Unstable angina with fatal outcome: Dynamic coronary thrombosis leading to infarction and/or sudden death: Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 1985, 71: 699–708. 10.1161/01.CIR.71.4.699PubMedCrossRef Falk E: Unstable angina with fatal outcome: Dynamic coronary thrombosis leading to infarction and/or sudden death: Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 1985, 71: 699–708. 10.1161/01.CIR.71.4.699PubMedCrossRef
18.
go back to reference Davies MJ, Thomas AC, Knapman PA, Hangartner JR: Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation 1986, 73: 418–427. 10.1161/01.CIR.73.3.418PubMedCrossRef Davies MJ, Thomas AC, Knapman PA, Hangartner JR: Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation 1986, 73: 418–427. 10.1161/01.CIR.73.3.418PubMedCrossRef
19.
go back to reference Topol EJ, Yadav JS: Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000, 101: 570–580. 10.1161/01.CIR.101.5.570PubMedCrossRef Topol EJ, Yadav JS: Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000, 101: 570–580. 10.1161/01.CIR.101.5.570PubMedCrossRef
20.
go back to reference Skyschally A, Schulz R, Gres P, Konietzka I, Martin C, Haude M, Erbel R, Heusch G: Coronary microembolization does not induce acute preconditioning against infarction in pigs - the role of adenosine. Cardiovasc Res 2004, 63: 313–322. 10.1016/j.cardiores.2004.04.003PubMedCrossRef Skyschally A, Schulz R, Gres P, Konietzka I, Martin C, Haude M, Erbel R, Heusch G: Coronary microembolization does not induce acute preconditioning against infarction in pigs - the role of adenosine. Cardiovasc Res 2004, 63: 313–322. 10.1016/j.cardiores.2004.04.003PubMedCrossRef
21.
go back to reference Irwin MW, Mak S, Mann DL, Qu R, Penninger JM, Yan A, Dawood F, Wen WH, Shou Z, Liu P: Tissue expression and immunolocalization of tumor necrosis factor-a in postinfarction dysfunctional myocardium. Circulation 1999, 99: 1492–1498. 10.1161/01.CIR.99.11.1492PubMedCrossRef Irwin MW, Mak S, Mann DL, Qu R, Penninger JM, Yan A, Dawood F, Wen WH, Shou Z, Liu P: Tissue expression and immunolocalization of tumor necrosis factor-a in postinfarction dysfunctional myocardium. Circulation 1999, 99: 1492–1498. 10.1161/01.CIR.99.11.1492PubMedCrossRef
22.
go back to reference Hori M, Gotoh K, Kitakaze M, Iwai K, Iwakura K, Sato H, Koretsune Y, Inoue M, Kitabatake A, Kamada T: Role of oxygen-derived free radicals in myocardial edema and ischemia in coronary microvascular embolization. Circulation 1991, 84: 828–840. 10.1161/01.CIR.84.2.828PubMedCrossRef Hori M, Gotoh K, Kitakaze M, Iwai K, Iwakura K, Sato H, Koretsune Y, Inoue M, Kitabatake A, Kamada T: Role of oxygen-derived free radicals in myocardial edema and ischemia in coronary microvascular embolization. Circulation 1991, 84: 828–840. 10.1161/01.CIR.84.2.828PubMedCrossRef
23.
go back to reference Canton M, Skyschally A, Menabò R, Boengler K, Gres P, Schulz R, Haude M, Erbel R, Di Lisa F, Heusch G: Oxidative modification of tropomyosin and myocardial dysfunction following coronary microembolization. Eur Heart J 2006, 27: 875–881. 10.1093/eurheartj/ehi751PubMedCrossRef Canton M, Skyschally A, Menabò R, Boengler K, Gres P, Schulz R, Haude M, Erbel R, Di Lisa F, Heusch G: Oxidative modification of tropomyosin and myocardial dysfunction following coronary microembolization. Eur Heart J 2006, 27: 875–881. 10.1093/eurheartj/ehi751PubMedCrossRef
24.
go back to reference Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G: A mechanism for the anti-inflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci U S A 1992, 89: 9991–9995. 10.1073/pnas.89.21.9991PubMedPubMedCentralCrossRef Cronstein BN, Kimmel SC, Levin RI, Martiniuk F, Weissmann G: A mechanism for the anti-inflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1. Proc Natl Acad Sci U S A 1992, 89: 9991–9995. 10.1073/pnas.89.21.9991PubMedPubMedCentralCrossRef
25.
go back to reference Williams CM, Coleman JW: Induced expression of mRNA for IL-5, IL-6, TNF-alpha, MIP-2 and IFN-gamma in immunologically activated rat peritoneal mast cells: inhibition by dexamethasone and cyclosporin A. Immunology 1995, 86: 244–249.PubMedPubMedCentral Williams CM, Coleman JW: Induced expression of mRNA for IL-5, IL-6, TNF-alpha, MIP-2 and IFN-gamma in immunologically activated rat peritoneal mast cells: inhibition by dexamethasone and cyclosporin A. Immunology 1995, 86: 244–249.PubMedPubMedCentral
26.
go back to reference Arras M, Strasser R, Mohri M, Doll R, Eckert P, Schaper W, Schaper J: Tumor necrosis factor-alpha is expressed by monocytes/macrophages following cardiac microembolization and is antagonized by cyclosporine. Basic Res Cardiol 1998, 93: 97–107. 10.1007/s003950050069PubMedCrossRef Arras M, Strasser R, Mohri M, Doll R, Eckert P, Schaper W, Schaper J: Tumor necrosis factor-alpha is expressed by monocytes/macrophages following cardiac microembolization and is antagonized by cyclosporine. Basic Res Cardiol 1998, 93: 97–107. 10.1007/s003950050069PubMedCrossRef
27.
go back to reference Henning RJ, Becker H, Vincent JL, Thijs L, Kalter E, Weil MH: Use of methylprednisolone in patients following acute myocardial infarction. Hemodynamic and metabolic effects. Chest 1981, 79: 186–194. 10.1378/chest.79.2.186PubMedCrossRef Henning RJ, Becker H, Vincent JL, Thijs L, Kalter E, Weil MH: Use of methylprednisolone in patients following acute myocardial infarction. Hemodynamic and metabolic effects. Chest 1981, 79: 186–194. 10.1378/chest.79.2.186PubMedCrossRef
Metadata
Title
Left ventricular remodeling with preserved function after coronary microembolization: the effect of methylprednisolone
Authors
Jianying Ma
Juying Qian
Shufu Chang
Zhangwei Chen
Hang Jin
Mengsu Zeng
Yunzeng Zou
Junbo Ge
Publication date
01-12-2014
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2014
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/2047-783X-19-7

Other articles of this Issue 1/2014

European Journal of Medical Research 1/2014 Go to the issue